The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Treatment of experimental arthritis by inducing immune tolerance with human adipose‐derived mesenchymal stem cells
Abstract
Objective: Rheumatoid arthritis (RA) is a chronic autoimmune disease caused by loss of immunologic self tolerance and characterized by chronic joint inflammation. Adult mesenchymal stem cells (MSCs) were recently found to suppress effector T cell responses and to have beneficial effects in various immune disorders. The purpose of this study was to examine a new therapeutic strategy for RA based on the administration of human adipose‐derived MSCs (AD‐MSCs). Methods: DBA/1 mice with collagen‐induced arthritis were treated with human AD‐MSCs after disease onset, and clinical scores were determined. Inflammatory response was determined by measuring the levels of different mediators of inflammation in the joints and serum. The Th1‐mediated autoreactive response was evaluated by determining the proliferative response and cytokine profile of draining lymph node cells stimulated with the autoantigen. The number of Treg cells and the suppressive capacity on self‐reactive Th1 cells were also determined. Results: Systemic infusion of human AD‐MSCs significantly reduced the incidence and severity of experimental arthritis. This therapeutic effect was mediated by down‐regulating the 2 deleterious disease components: the Th1‐driven autoimmune and inflammatory responses. Human AD‐MSCs decreased the production of various inflammatory cytokines and chemokines, decreased antigen‐specific Th1/Th17 cell expansion, and induced the production of antiinflammatory interleukin‐10 in lymph nodes and joints. Human AD‐MSCs also induced de novo generation of antigen‐specific CD4+CD25+FoxP3+ Treg cells with the capacity to suppress self‐reactive T effector responses. Conclusion: Human AD‐MSCs emerge as key regulators of immune tolerance by inducing the generation/activation of Treg cells and are thus attractive candidates for a cell‐based therapy for RA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies
Zuk, P. A., Zhu, M., Mizuno, H., Huang, J., Futrell, J. W., Katz, A. J., Benhaim, P., Lorenz, H. P., & Hedrick, M. H. (2001) · Tissue Engineering · doi:10.1089/107632701300062859 · Cited by 7,956
Caplan, A. I. (1991) · Journal of Orthopaedic Research · doi:10.1002/jor.1100090504 · Cited by 6,548
Regulatory T Cells and Immune Tolerance
Sakaguchi, S., Yamaguchi, T., Nomura, T., & Ono, M. (2008) · Cell · doi:10.1016/j.cell.2008.05.009 · Cited by 5,325
Human mesenchymal stem cells modulate allogeneic immune cell responses
Aggarwal, S., & Pittenger, M. F. (2005) · Blood · doi:10.1182/blood-2004-04-1559 · Cited by 4,511
Evolving concepts of rheumatoid arthritis
Firestein, G. S. (2003) · Nature · doi:10.1038/nature01661 · Cited by 3,605
A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E., & Roncarolo, M. G. (1997) · Nature · doi:10.1038/39614 · Cited by 3,588
Le Blanc, K., Frassoni, F., Ball, L., Locatelli, F., Roelofs, H., Lewis, I., Lanino, E., Sundberg, B., Bernardo, M. E., Remberger, M., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60690-x · Cited by 2,695
ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.397 · Cited by 2,514
Bartholomew, A., Sturgeon, C., Siatskas, M., Ferrer, K., McIntosh, K., Patil, S., Hardy, W., Devine, S., Ucker, D., Deans, R., et al. (2002) · Experimental Hematology · doi:10.1016/s0301-472x(01)00769-x · Cited by 2,295
Immunomodulatory properties of mesenchymal stromal cells
Nauta, A. J., & Fibbe, W. E. (2007) · Blood · doi:10.1182/blood-2007-02-069716 · Cited by 1,788
Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy
Zappia, E., Casazza, S., Pedemonte, E., Benvenuto, F., Bonanni, I., Gerdoni, E., Giunti, D., Ceravolo, A., Cazzanti, F., Frassoni, F., et al. (2005) · Blood · doi:10.1182/blood-2005-04-1496 · Cited by 1,430
Jiang, X.-X., Zhang, Y., Liu, B., Zhang, S.-X., Wu, Y., Yu, X.-D., & Mao, N. (2005) · Blood · doi:10.1182/blood-2004-02-0586 · Cited by 1,346
Liechty, K. W., MacKenzie, T. C., Shaaban, A. F., Radu, A., Moseley, A. B., Deans, R., Marshak, D. R., & Flake, A. W. (2000) · Nature Medicine · doi:10.1038/81395 · Cited by 1,215
Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells
Glennie, S., Soeiro, I., Dyson, P. J., Lam, E. W.-F., & Dazzi, F. (2005) · Blood · doi:10.1182/blood-2004-09-3696 · Cited by 1,150
Beyth, S., Borovsky, Z., Mevorach, D., Liebergall, M., Gazit, Z., Aslan, H., Galun, E., & Rachmilewitz, J. (2005) · Blood · doi:10.1182/blood-2004-07-2921 · Cited by 1,034
Puissant, B., Barreau, C., Bourin, P., Clavel, C., Corre, J., Bousquet, C., Taureau, C., Cousin, B., Abbal, M., Laharrague, P., et al. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05409.x · Cited by 957
Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells
Sato, K., Ozaki, K., Oh, I., Meguro, A., Hatanaka, K., Nagai, T., Muroi, K., & Ozawa, K. (2007) · Blood · doi:10.1182/blood-2006-02-002246 · Cited by 954
Yañez, R., Lamana, M. L., García‐Castro, J., Colmenero, I., Ramírez, M., & Bueren, J. A. (2006) · STEM CELLS · doi:10.1634/stemcells.2006-0228 · Cited by 719
González, M. A., Gonzalez–Rey, E., Rico, L., Büscher, D., & Delgado, M. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.11.041 · Cited by 631
Self-citationAugello, A., Tasso, R., Negrini, S. M., Cancedda, R., & Pennesi, G. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22511 · Cited by 587
Maccario, R., Podestà, M., Moretta, A., Cometa, A. M., Comoli, P., Montagna, D., Daudt, L. E., Ibatici, A., Piaggio, G., Pozzi, S., et al. (2005) · PubMed · Cited by 580
van Amelsfort, J. M. R., Jacobs, K. M. G., Bijlsma, J. W. J., Lafeber, F. P. J. G., & Taams, L. S. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20499 · Cited by 531
Effective treatment of collagen‐induced arthritis by adoptive transfer of CD25+ regulatory T cells
Morgan, M. E., Flierman, R., van Duivenvoorde, L. M., Witteveen, H. J., van Ewijk, W., van Laar, J. M., de vries, R. R. P., & Toes, R. E. M. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21195 · Cited by 385
Delgado, M., Abad, C., Martinez, C., Leceta, J., & Gomariz, R. P. (2001) · Nature Medicine · doi:10.1038/87887 · Cited by 383
Self-citationImmune modulation by mesenchymal stem cells
Rasmusson, I. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.03.019 · Cited by 374
Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction
Prevosto, C., Zancolli, M., Canevali, P., Zocchi, M. R., & Poggi, A. (2007) · Haematologica · doi:10.3324/haematol.11240 · Cited by 368
Haniffa, M. A., Wang, X.-N., Holtick, U., Rae, M., Isaacs, J. D., Dickinson, A. M., Hilkens, C. M. U., & Collin, M. P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1595 · Cited by 346
CD25+ cell depletion hastens the onset of severe disease in collagen‐induced arthritis
Morgan, M. E., Sutmuller, R. P. M., Witteveen, H. J., van Duivenvoorde, L. M., Zanelli, E., Melief, C. J. M., Snijders, A., Offringa, R., de Vries, R. R. P., & Toes, R. E. M. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11063 · Cited by 305
Grinnemo, K. H., Månsson, A., Dellgren, G., Klingberg, D., Wardell, E., Drvota, V, Tammik, C., Holgersson, J., Ringdén, O., Sylvén, C., et al. (2004) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2003.07.037 · Cited by 294
Role of Toll‐Like Receptors on Human Adipose‐Derived Stromal Cells
Hwa Cho, H., Bae, Y. C., & Jung, J. S. (2006) · STEM CELLS · doi:10.1634/stemcells.2006-0189 · Cited by 276
Kasama, T., Strieter, R. M., Lukacs, N. W., Lincoln, P. M., Burdick, M. D., & Kunkel, S. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117993 · Cited by 270
Cui, L., Yin, S., Liu, W., Li, N., Zhang, W., & Cao, Y. (2007) · Tissue Engineering · doi:10.1089/ten.2006.0315 · Cited by 265
Interleukin‐10 inhibition of the progression of established collagen‐induced arthritis
Walmsley, M., Katsikis, P. D., Abney, E., Parry, S., Williams, R. O., Maini, R. N., & Feldmann, M. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390318 · Cited by 261
Seki, N., Sudo, Y., Yoshioka, T., Sugihara, S., Fujitsu, T., Sakuma, S., Ogawa, T., Hamaoka, T., Senoh, H., & Fujiwara, H. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.5.1477 · Cited by 260
Li, Y.-P., Paczesny, S., Lauret, E., Poirault, S., Bordigoni, P., Mekhloufi, F., Hequet, O., Bertrand, Y., Ou-Yang, J.-P., Stoltz, J.-F., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1598 · Cited by 250
Immunogenicity of Adult Mesenchymal Stem Cells: Lessons from the Fetal Allograft
Barry, F. P., Murphy, J. M., English, K., & Mahon, B. P. (2005) · Stem Cells and Development · doi:10.1089/scd.2005.14.252 · Cited by 201
Ohnishi, S., Yanagawa, B., Tanaka, K., Miyahara, Y., Obata, H., Kataoka, M., Kodama, M., Ishibashi-Ueda, H., Kangawa, K., Kitamura, S., et al. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.10.003 · Cited by 196
Horwitz, D. A., Zheng, S. G., & Gray, J. D. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0503228 · Cited by 193
Zheng, Z., Li, X. Y., Ding, J., Jia, J., & Zhu, P. (2007) · Rheumatology · doi:10.1093/rheumatology/kem284 · Cited by 155
Li, L., Godfrey, W. R., Porter, S. B., Ge, Y. G., June, C. H., Blazar, B. R., & Boussiotis, V. A. (2005) · Blood · doi:10.1182/blood-2005-04-1531 · Cited by 133
Regulatory CD4+ T cells and the control of autoimmune disease
Wraith, D. C., Nicolson, K., & Whitley, N. T. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.09.015 · Cited by 115
The immunosuppressive drug FK778 induces regulatory activity in stimulated human CD4+CD25− T cells
Kreijveld, E., Koenen, H. J. P. M., Hilbrands, L. B., van Hooff, H. P., & Joosten, I. (2006) · Blood · doi:10.1182/blood-2006-05-021931 · Cited by 21
Cited by
Clinical Trials with Mesenchymal Stem Cells: An Update
Squillaro, T., Peluso, G., & Galderisi, U. (2016) · Cell Transplantation · doi:10.3727/096368915x689622 · Cited by 1,395
Human mesenchymal stem cells - current trends and future prospective
Ullah, I., Subbarao, R. B., & Rho, G. J. (2015) · Bioscience Reports · doi:10.1042/bsr20150025 · Cited by 1,337
Mesenchymal stem cells and immunomodulation: current status and future prospects
Gao, F., Chiu, S. M., Motan, D. A. L., Zhang, Z., Chen, L., Ji, H.-L., Tse, H.-F., Fu, Q.-L., & Lian, Q. (2016) · Cell Death & Disease · doi:10.1038/cddis.2015.327 · Cited by 1,121
Mesenchymal Stem Cells: Mechanisms of Inflammation
Singer, N. G., & Caplan, A. I. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130230 · Cited by 851
Strioga, M., Viswanathan, S., Darinskas, A., Slaby, O., & Michalek, J. (2012) · Stem Cells and Development · doi:10.1089/scd.2011.0722 · Cited by 825
Metadata
- Authors
- González, M. A., Gonzalez‐Rey, E., Rico, L., Büscher, D., & Delgado, M.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2009-03-30
- Volume
- 60
- Issue
- 4
- Pages
- 1006-1019
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W1976371737
- Cited by
- 489
- References
- 43
- FWCI
- 19.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.